Skip to main content
. 2011 Apr;178(4):1416–1428. doi: 10.1016/j.ajpath.2010.12.051

Table 1.

Expression of Potential Phagocytic Receptors in Central Nervous System Cells

Receptor Ligand Relevance Expression detected
References
Microglia Astrocytes Neurons
Phosphatidylserine receptors
 BAI1 PS Uptake of apoptotic cells × × × 1
 TIM4 PS Uptake of apoptotic cells 1
 Scavenger family receptors PS Uptake of apoptotic cells 1, 89
Opsonin receptors
 MerTK Gas6 (binds PS) Uptake of POS, apoptotic cells × × 3, 26
Gas 6 production × ×
 αvβ3/5 integrin Mfge8 (binds PS) Uptake of apoptotic cells, uptake of Aβ × × × 3, 79
MFGE8 production ×
 Complement receptor Complement Uptake of apoptotic cells, uptake of Aβ × × × 22, 55
Complement production × × ×
 FcR Immunoglobulins Uptake of apoptotic cells, uptake of Aβ × × × 64, 90
Immunoglobulin production
Pattern recognition receptors
 TLRs/CD14 Uptake of apoptotic cells, uptake of Aβ × × × 3, 91, 92, 93
 FPRL1 Uptake of Aβ × × × 94, 95
 RAGE Uptake of Aβ, BBB-associated Aβ receptor × × × 5, 95, 96, 97
 CD36 scavenger receptor Aβ, α-synuclein Uptake of Aβ × × 42, 95, 98, 99
Lipoprotein receptors
 LDLR ApoE Uptake of Aβ-ApoE complexes, mediate Aβ-induced changes in ApoE production × × 3, 95
ApoE production ×
 LRP1 ApoE Uptake of Aβ-ApoE complexes, BBB-associated Aβ receptor × × 3, 95
Uptake of Aβ-ApoJ complexes ×
 LRP2/megalin Clusterin (ApoJ) Clusterin production × × × 55, 75, 95

Aβ, amyloid-β; Apo, apolipoprotein; BAI1, brain-specific angiogenesis inhibitor-1; BBB, blood-brain barrier; FcR, Fc receptor; FPRL1, formyl peptide receptor-like 1; Gas6, growth-arrest specific 6; LDLR, low density lipoprotein receptor; LRP, low density lipoprotein receptor-related; MerTK, Mer receptor tyrosine kinase; Mfge8, milk fat globule-EGF factor 8 (also known as lactadherin); POS, photoreceptor outer segments; PS, phosphatidylserine; RAGE, receptor for advanced glycation endproducts; TIM4, T-cell immunoglobulin and mucin-domain-containing molecule 4; TLR, Toll-like receptor.

Asterisk indicates that the ligand is an opsonin (bridging molecule), rather than the direct target of the phagocytic receptor.